BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30868060)

  • 1. A risk score model for the prediction of osteosarcoma metastasis.
    Dong S; Huo H; Mao Y; Li X; Dong L
    FEBS Open Bio; 2019 Mar; 9(3):519-526. PubMed ID: 30868060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma.
    Sun W; Ma X; Shen J; Yin F; Wang C; Cai Z
    Int J Mol Med; 2016 Aug; 38(2):466-74. PubMed ID: 27353415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
    He Y; Ma J; Ye X
    Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray.
    Shi Z; Zhou H; Pan B; Lu L; Wei Z; Shi L; Yao X; Kang Y; Feng S
    Mol Med Rep; 2017 Nov; 16(5):7423-7431. PubMed ID: 28944885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma.
    Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H
    J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying osteosarcoma metastasis associated genes by weighted gene co-expression network analysis (WGCNA).
    Tian H; Guan D; Li J
    Medicine (Baltimore); 2018 Jun; 97(24):e10781. PubMed ID: 29901575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma.
    Kobayashi E; Masuda M; Nakayama R; Ichikawa H; Satow R; Shitashige M; Honda K; Yamaguchi U; Shoji A; Tochigi N; Morioka H; Toyama Y; Hirohashi S; Kawai A; Yamada T
    Mol Cancer Ther; 2010 Mar; 9(3):535-44. PubMed ID: 20159990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Novel Target Genes for Osteosarcoma Therapy Based on Comprehensive Bioinformatic Analysis.
    Zhou X; Fan Y; Ye W; Jia B; Yang Y; Liu Y
    DNA Cell Biol; 2020 Jul; 39(7):1172-1180. PubMed ID: 32584170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Prognostic RBPs in Osteosarcoma.
    Li B; Fang L; Wang B; Yang Z; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Pathogenic Genes and Transcription Factors in Osteosarcoma.
    Yang C; Huang D; Ma C; Ren J; Fu L; Cheng C; Li B; Shi X
    Pathol Oncol Res; 2020 Apr; 26(2):1041-1048. PubMed ID: 30982140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
    Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
    Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Logistic regression analysis for the identification of the metastasis-associated signaling pathways of osteosarcoma.
    Liu Y; Sun W; Ma X; Hao Y; Liu G; Hu X; Shang H; Wu P; Zhao Z; Liu W
    Int J Mol Med; 2018 Mar; 41(3):1233-1244. PubMed ID: 29328361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients.
    Wu B; Wang Z; Lin N; Yan X; Lv Z; Ying Z; Ye Z
    Medicine (Baltimore); 2021 Apr; 100(14):e24118. PubMed ID: 33832059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
    Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
    Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs.
    Heng L; Jia Z; Bai J; Zhang K; Zhu Y; Ma J; Zhang J; Duan H
    Mol Med Rep; 2017 May; 15(5):2829-2836. PubMed ID: 28260111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis.
    Li M; Jin X; Li H; Wu G; Wang S; Yang C; Deng S
    BMC Cancer; 2020 Jan; 20(1):65. PubMed ID: 31992246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Key Genes Affecting Results of Hyperthermia in Osteosarcoma Based on Integrative ChIP-Seq/TargetScan Analysis.
    Shi Y; Yang F; Wei S; Xu G
    Med Sci Monit; 2017 Apr; 23():2042-2048. PubMed ID: 28453502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma.
    Niu F; Zhao S; Xu CY; Chen L; Ye L; Bi GB; Tian G; Gong P; Nie TH
    Asian Pac J Cancer Prev; 2014; 15(24):10797-801. PubMed ID: 25605179
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Li S; Wu X; Pei Y; Wang W; Zheng K; Qiu E; Zhang X
    DNA Cell Biol; 2019 Nov; 38(11):1323-1337. PubMed ID: 31536386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.